GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Teleflex Inc (FRA:TBH) » Definitions » Institutional Ownership

Teleflex (FRA:TBH) Institutional Ownership : 91.85% (As of Jun. 09, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Teleflex Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Teleflex's institutional ownership is 91.85%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Teleflex's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Teleflex's Float Percentage Of Total Shares Outstanding is 63.01%.


Teleflex Institutional Ownership Historical Data

The historical data trend for Teleflex's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teleflex Institutional Ownership Chart

Teleflex Historical Data

The historical data trend for Teleflex can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 97.24 94.80 90.71 90.75 92.71 92.46 92.40 92.29 91.83 91.85

Teleflex Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Teleflex (FRA:TBH) Business Description

Traded in Other Exchanges
Address
550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2022 sales), interventional (16%), anesthesia (14%), surgical (14%), interventional urology (12%), original-equipment manufacturing (10%), and all other (10%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Teleflex (FRA:TBH) Headlines

No Headlines